Christopher Astle

Christopher Astle

Director/Miembro de la Junta en
Oak Bay Biosciences, Inc.
.
47 años
Health Technology
Consumer Services
Commercial Services

Perfil

Christopher Astle was the founder of Think Forwards, a company founded in 2017 where he held the title of Chief Executive Officer from 2017 to 2020.
He is currently working as a Director at Oak Bay Biosciences, Inc. since 2020 and as a Director at Healome Therapeutics Ltd. since 2021.
In his former positions, Dr. Astle worked as Vice President-Finance at Lundbeck Seattle BioPharmaceuticals, Inc. from 2019 to 2020, Associate VP-International Division Finance at Allergan (Canada) from 2016 to 2017, Chief Financial Officer at CFO Centre Ltd. from 2020 to 2021, Senior VP, Chief Financial & Accounting Officer at Zymeworks, Inc. from 2022 to 2024, and Chief Financial Officer & Senior Vice President at Zymeworks BC, Inc. from 2022 to 2024.
Dr. Astle obtained a graduate degree from The University of Liverpool and a doctorate degree from the University of Bristol.

Cargos activos de Christopher Astle

EmpresasCargoInicio
Oak Bay Biosciences, Inc.
Director/Miembro de la Junta 01/01/2020
Director/Miembro de la Junta 01/01/2021

Antiguos cargos conocidos de Christopher Astle.

EmpresasCargoFin
Director Financiero/CFO 01/09/2024
ZYMEWORKS INC. Director Financiero/CFO 31/03/2024
Director Financiero/CFO 01/03/2021
ALDER BIOPHARMACEUTICALS, INC. Corporate Officer/Principal 01/02/2020
Think Forwards
Director Ejecutivo 01/01/2020
Ver el detalle de la experiencia de Christopher Astle.

Formación de Christopher Astle.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

10

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Think Forwards

Oak Bay Biosciences, Inc.

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Christopher Astle